Published in Bacteriol Rev on September 01, 1961
FACTORS INFLUENCING THE CLEARANCE OF BACTERIA BY THE LUNG. J Clin Invest (1964) 2.79
Aerogenic immunization of man with live Tularemia vaccine. Bacteriol Rev (1966) 2.42
Induction and expression of immunity after BCG immunization. Infect Immun (1977) 2.06
Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG. Infect Immun (2004) 1.44
Host-parasite relationships in experimental airborne tuberculosis. I. Preliminary studies in BCG-vaccinated and nonvaccinated animals. J Bacteriol (1966) 1.39
Listeria pneumonitis: influence of route of immunization on resistance to airborne infection. Infect Immun (1979) 1.16
Delayed-type hypersensitivity and immunity against aerogenic tuberculosis in guinea pigs. Infect Immun (1974) 1.14
Perspectives on clinical and preclinical testing of new tuberculosis vaccines. Clin Microbiol Rev (2010) 1.13
Macrophage activation and resistance to pulmonary tuberculosis. Infect Immun (1980) 1.10
Immunogenicity of an aerogenic BCG vaccine in T-cell-depleted and normal mice. Infect Immun (1975) 1.02
Temporal development of resistance to pulmonary tuberculosis in Swiss albino mice. J Exp Med (1971) 0.88
Intranasal administration of Mycobacterium bovis BCG induces superior protection against aerosol infection with Mycobacterium tuberculosis in mice. Clin Vaccine Immunol (2014) 0.86
Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis? Vaccine (2015) 0.82
Increased susceptibility of splenectomized mice to infection after exposure to an aerosolized suspension of type III Streptococcus pneumoniae. Infect Immun (1978) 0.80
Aerosol vaccination with tetanus toxoid. Bacteriol Rev (1966) 0.80
Hazard inherent in microbial tracers: reduction of risk by the use of Bacillus stearothermophilus spores in aerobiology. Appl Microbiol (1972) 0.77
New sampler for the collection, sizing, and enumeration of viable airborne particles. J Bacteriol (1958) 18.57
Evaluation of the method of quantitative airborne infection and its use in the study of the pathogenesis of tuberculosis. Am Rev Tuberc (1950) 3.61
An apparatus for airborne infection of mice. Proc Soc Exp Biol Med (1952) 3.07
The inhalation test as a diagnostic procedure with special emphasis on the house dust allergen. J Allergy (1952) 1.15
Distemper Immunization of Ferrets by Nebulization with Egg Adapted Virus. Science (1954) 1.13
Distemper immunization of mink by air-borne infection with egg-adapted virus. J Am Vet Med Assoc (1954) 1.12
[Experience in massive aerogenic vaccination against anthrax]. Voen Med Zh (1959) 1.01
Reduction in the Vital Capacity of Asthmatic Subjects Following Exposure to Aerosolized Pollen Extracts. Science (1947) 0.95
Direct bronchial testing and hyposensitization in asthmatics using aerosolized dust extract. Int Arch Allergy Appl Immunol (1957) 0.91
Evaluation of therapeutic substances employed for the relief of bronchospasm. VII. Combinations of diphenhydramine with ephedrine and aminophylline. J Allergy (1950) 0.91
Specific serum agglutination of erythrocytes sensitized with extracts of tubercle bacilli. J Exp Med (1948) 11.08
Sputum digestion and decontamination with N-acetyl-L-cysteine-sodium hydroxide for culture of mycobacteria. Am Rev Respir Dis (1963) 9.11
Bacteriology of tuberculosis: laboratory methods. Am J Public Health Nations Health (1958) 3.71
Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report. Am Rev Tuberc (1954) 3.36
An apparatus for airborne infection of mice. Proc Soc Exp Biol Med (1952) 3.07
Studies on isoniazid and tubercle bacilli. III. The isolation, drug-susceptibility, and catalase-testing of tubercle bacilli from isoniazid-treated patients. Am Rev Tuberc (1954) 2.98
Studies on isoniazid and tubercle bacilli. II. The growth requirements, catalase activities, and pathogenic properties of isoniazid-resistant mutants. Am Rev Tuberc (1954) 2.62
The role of biotin and carbon dioxide in the cultivation of Mycobacterium tuberculosis. J Bacteriol (1955) 2.60
A hemolytic modification of the hemagglutination test for antibodies against tubercle bacillus antigens. J Clin Invest (1950) 2.46
Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli. Science (1953) 2.29
Combined drug treatment of tuberculosis. I. Prevention of emergence of mutant populations of tubercle bacilli resistant to both streptomycin and isoniazid in vitro. J Clin Invest (1959) 2.20
Cytochemical reaction of virulent tubercle bacilli. Am Rev Tuberc (1948) 2.14
Antigens of tubercle bacillus involved in hemagglutination and hemolysis reactions. Bull N Y Acad Med (1952) 1.98
Sterilization of tubercle bacilli by isonicotinic acid hydrazide and the incidence of variants resistant to the drug in vitro. Am Rev Tuberc (1952) 1.93
The effect of wetting agents on the growth of tubercle bacilli. J Exp Med (1948) 1.90
Interface enrichment of methylene blue by fatty acids with microanalytic applications. Science (1957) 1.84
Studies on isoniazid and tubercle bacilli. I. The isolation of isoniazid-resistant mutants in vitro. Am Rev Tuberc (1954) 1.63
INFECTIVITY, PATHOGENICITY AND SULPHOLIPID FRACTION OF SOME INDIAN AND BRITISH STRAINS OF TUBERCLE BACILLI. Tubercle (1963) 1.43
The experimental analysis of virulence of tubercle bacilli. Bull N Y Acad Med (1950) 1.36
The hemagglutination test in tuberculosis. Am Rev Tuberc (1950) 1.35
The effects of some sulfhydryl compounds on growth of catalase-positive and catalase-negative tubercle bacilli. Am Rev Tuberc (1956) 1.35
Peripheral neuritis in tuberculous patients treated with isoniazid. Am Rev Tuberc (1954) 1.29
Studies on the gaseous content of tuberculous cavities. Am Rev Respir Dis (1959) 1.29
[A case of human infection by Mycobacterium ulcerans in the western hemisphere; preliminary note]. Int J Lepr (1954) 1.24
Chemotherapy of tuberculosis. Adv Intern Med (1956) 1.21
Effect of para-aminosalicylic acid on serum isoniazid levels in man. Proc Soc Exp Biol Med (1956) 1.16
Serum isoniazid levels and catalase activities of tubercle bacilli from isoniazid-treated patients. Am J Med Sci (1957) 1.16
Changing concepts in the treatment of pulmonary tuberculosis. Ann Intern Med (1957) 1.16
Airborne immunization against tuberculosis. Science (1958) 1.13
Implications of the phenomenon of open cavity healing for the chemotherapy of pulmonary tuberculosis. Am Rev Tuberc (1955) 1.13
Techniques of drug-resistance tests. Am Rev Tuberc (1954) 1.12
Infectivity and pathogenicity of Indian and British strains of tubercle bacilli studied by aerogenic infection of guinea pigs. Am Rev Respir Dis (1963) 1.10
Observations on the pathogenicity of isoniazid-resistant mutants of tubercle bacilli for tuberculous patients. Am Rev Tuberc (1955) 1.06
Clinical evaluation of isoniazid. Am Rev Tuberc (1954) 1.02
Dosages of isoniazid and streptomycin for routine chemotherapy of tuberculosis. Tubercle (1960) 0.99
Tuberculin hypersensitivity in tuberculous infants treated with isoniazid. N Engl J Med (1955) 0.98
Comparative study of the vaccinating properties of BCG and its isoniazid-resistant mutant in guinea pigs. Am Rev Tuberc (1957) 0.97
Prophylaxis of isoniazid neuropathy with pyridoxine. N Engl J Med (1956) 0.95
Combined drug treatment of tuberculosis. II. Studies of antimicrobially-active isoniazid and streptomycin serum levels in adult tuberculous patients. J Clin Invest (1959) 0.93
Carbon dioxide-impermeable plastic bags for artificial cultivation of tubercle bacilli. Am Rev Respir Dis (1963) 0.90
Combined drug treatment of tuberculosis. III. Clinical application of the principles of appropriate and adequate chemotherapy to the treatment of pulmonary tuberculosis. J Clin Invest (1959) 0.90
Media for tubercle bacilli. Am Rev Tuberc (1947) 0.87
The handling of the poor risk patient with pulmonary tuberculosis: antimicrobial therapy, cardio-pulmonary function and surgery. Dis Chest (1956) 0.82
DYNAMIC ASPECTS OF THE STERILIZING ACTION OF ISONIAZID ON MYCOBACTERIUM TUBERCULOSIS. Am Rev Respir Dis (1963) 0.81
Quantitative inhalation challenge in allergic asthma. J Allergy (1963) 0.81
Experimental penicillin prophylaxis of staphylococcal infection in rabbits. Proc Soc Exp Biol Med (1960) 0.80
Fatal tuberculous meningitis developing during isoniazid-streptomycin therapy. Am Rev Tuberc (1955) 0.79
Combined drug treatment of tuberculosis. IV. Bacteriologic studies on the sputum and resected pulmonary lesions of tuberculous patients. J Clin Invest (1959) 0.79
Ambulation of patients with pulmonary tuberculosis under protection of chemotherapy; a preliminary report. Am Rev Tuberc (1954) 0.79
Chemoprophylaxis with isoniazid against aerogenic tuberculous infection in the guinea pig. Am Rev Respir Dis (1962) 0.77
Laboratory aids to diagnosis and therapy. Annu Rev Med (1954) 0.76
Serologic reaction in tuberculosis. Am Rev Tuberc (1948) 0.75
The binding of various long-chain fatty acids by serum albumin. Clin Chim Acta (1957) 0.75
Certain effects of streptomycin on mycobacteria in vitro. Am Rev Tuberc (1946) 0.75
Comparative susceptibilities of different strains of mice to experimental infection with mammalian tubercle bacilli. J Bacteriol (1947) 0.75
Effect of pyridoxine on concentrations of active isoniazid in serum. Am Rev Respir Dis (1960) 0.75
[A plan for the treatment of pulmonary tuberculosis. I. Experiences in 173 patients with streptomycin- and isoniazid-sensitive tubercle bacilli]. Med Nov (1959) 0.75
Medical treatment of tuberculosis: preliminary report on early ambulation of tuberculous patients under the cover of chemotherapy. Trans Annu Meet Natl Tuberc Assoc (1954) 0.75
The treatment of primary tuberculosis in infancy. J Pediatr (1955) 0.75
Healing of the open cavity in pulmonary tuberculosis under chemotherapy. Am Rev Tuberc (1956) 0.75
Effect of pyrazinamide on antimicrobially active serum isoniazid. Dis Chest (1960) 0.75
Chemotherapy of childhood tuberculosis. Am J Dis Child (1961) 0.75
THE INFECTIVITY AND PATHOGENICITY OF INDIAN TUBERCLE BACILLI. Am Rev Respir Dis (1963) 0.75
Some thoughts on results following intermittent streptomycin in pulmonary tuberculosis. Dis Chest (1959) 0.75
The residual lesion in pulmonary tuberculosis requiring surgery. A review of 100 sputum-negative patients consecutively operated on. N Engl J Med (1960) 0.75
[A plan for the treatment of pulmonary tuberculosis. II. Experiences in 173 patients with streptomycin and isoniazid-senstive tubercle bacilli]. Med Nov (1959) 0.75
[Various new data on the biology of Koch's bacillus (referring to a recent report)]. Medicina (B Aires) (1954) 0.75
Biologic changes in sulfonamide-resistant Mycobacterium ranae. J Bacteriol (1946) 0.75
The open-negative problem. Am Rev Respir Dis (1959) 0.75
Attenuation of isoniazid-resistant mutants of tubercle bacilli and host hypersensitivity to tuberculin. Proc Soc Exp Biol Med (1955) 0.75
Infection of mice with tubercle bacilli grown in tween-albumin liquid medium. Proc Soc Exp Biol Med (1947) 0.75
The effect of tubercle bacilli on the antigenicity of a synthetic ester of oleic acid. J Immunol (1947) 0.75
Developments in the laboratory: the growth requirements and pathogenic properties of isoniazid-resistant tubercle bacilli. Trans Annu Meet Natl Tuberc Assoc (1954) 0.75
Isoniazid resistance. Lancet (1955) 0.75
THE EFFECT OF NEAR-ULTRAVIOLET LIGHT ON STAPHYLOCOCCI AND MYCOBACTERIA IN DROPLET NUCLEI. Am Rev Respir Dis (1965) 0.75
Effect of increasing dosage of streptomycin sulfate on serum levels of antimicrobially active drug. Dis Chest (1961) 0.75
Studies on the effect of various derivatives of para-aminosalicylic acid on serum levels of antimicrobially active isoniazid. Acta Tuberc Scand (1960) 0.75
Differential characteristics of virulent and avirulent variants of mammalian tubercle bacilli. J Bacteriol (1947) 0.75
Tuberculosis in childhood: some aspects of prevention, diagnosis and treatment. J Ky State Med Assoc (1958) 0.75
THE EFFECT OF NEAR-ULTRAVIOLET LIGHT ON CULTURE MEDIA. Am Rev Respir Dis (1965) 0.75
BACTERICIDAL EFFECT OF ISONIAZID AS A FUNCTION OF TIME. Am Rev Respir Dis (1965) 0.75
Tuberculin testing, chemoprophylaxis, and BCG vaccination. Isr Med J (1959) 0.75